MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
-
BYD Drops Rotating Screens in New Models Due to Tech Limits
-
E Pellicci Pop-Up at Selfridges Brings Back Nostalgic School Cake
-
Ryanair Flight from Rome Makes Emergency Landing in Lisbon After Bomb Threat
-
Coronation Street's Debbie Webster Steps Down as Dementia Storyline Intensifies
-
Maltese President Visits London Hospital to Support Families Facing Medical Care Challenges
-
Maxon Expands Creative Possibilities with New Touch and Spatial Experiences in Cinema 4D and ZBrush for Apple Products
-
Prometheus Laboratories Presents Research Showing Superior Performance of MASH Precis Fibrosis Score in Identifying Treatment-Eligible Patients
-
ACE Survey Finds 35% of Adults Wouldn't Have Returned to School Without Online Options
-
SMX: Plastic Recycling is no Longer a Favor; it's a Must
-
Globa Terra Acquisition Corporation Reports Encouraging Investor Support Ahead of November 9 Extension Vote
-
Gladstone Investment Corporation Acquires Majority Stake in McFarlane Toys
-
RenX Microtec Mill Is Built; Power and Commissioning Are Next
-
Watermelon Z Strain Guide Clarifies Conflicting Breeder Information and Genetic Lineage
-
MADE in America is Great Again; SMX has the Proof
-
Patterson-UTI Reports Drilling Activity for October 2026
-
Green Leaf Innovations (OTC PINK:GRLF) Reports 51% Sequential Revenue Growth and 115% Net Income Increase in Q2 2026
-
IRS Reports a Record $5.6 Trillion Collected in FY 2026 - Clear Start Tax Explains What Record Collection Performance Means for People Who Still Owe
-
Ambee and meteoblue Announce Partnership on Climate Risk and Resilience Data
-
RAEK Unveils New Designs for Creator Vault, Its First Private AI Appliance
-
Stagwell Media Names Kate Richling as Chief Brand and Communications Officer
-
Plastic Recycling has a New Passport; SMX is the Stamp
-
Eylsia Nicolas Returns to Her Signature Sound as "Where or When" Debuts at #4 on the Groover U.S. Rock Charts
-
Wipeboard Launches Ghost.Wipeboard.io, a Case Management Workspace Built for Paranormal Investigation Teams
-
OSR Health Exercises $15 Million VXM01 Equity Option, Elects Settlement Through Staged Convertible Notes
-
Valsoft's TAG Software Group Enters the Content Operations Market with the Acquisition of Chalco
-
Nathan Charnes Elected 45th President of the PGA of America
-
21- and 23-Year-Old Co-Founders Build Multi-Million Dollar Global BPO in Under 18 Months
-
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates
-
Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
-
BioScience Health Innovations, Inc. Announces Its Subsidiary Vitalcore Research has Executed Master Distribution Agreement with Rule Imports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 06
-
Record Seven Muslim Americans Elected to US Congress in Historic Midterm Shift
-
Luxembourg Minister Warns Trump of 'Lame Duck' Risk Amid Global Updates
-
Samsung Leads Global DRAM Market as SK Hynix Gains Share
-
South Korea Proposes Fourth Delay of Cryptocurrency Gains Tax to 2029
-
Kakao Details Spinoff Plan to Monetize AI Through KakaoTalk
-
ASIC Fines Mona Museum Owner's Company for Late Financial Report
-
Business Leaders Criticize Productivity Commission Inquiry Scope
-
SCANDIC FINANCE ने एलेक्स बोडी को समूह का उपाध्यक्ष नियुक्त किया
-
SCANDIC FINANCE แต่งตั้งอเล็กซ์ โบดี เป็นรองประธานกลุ่มบริษัท
-
SCANDIC FINANCE Grubu, Alex Bodi’yi başkan yardımcılığına atadı
-
Alex Bodi wiceprezesem grupy SCANDIC FINANCE
-
Алекс Боди е назначен за вицепрезидент на групата SCANDIC FINANCE
-
Alex Bodi a SCANDIC FINANCE vállalatcsoport új alelnöke
-
Ο Άλεξ Μπόντι νέος αντιπρόεδρος του ομίλου SCANDIC FINANCE
-
Cape Town’s Two-Tier Policing System Emerges From Private Funding
-
Milky Lane Food Truck Makes First Penrith Appearance This Weekend
-
Wild Horse Nine Review: John Malkovich Anchors Martin McDonagh’s Dark Comedy
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
GENEVAD, SE / ACCESS Newswire / March 19, 2026 / MindMaze Therapeutics Holding SA (SIX:MMTX) (the Company), a global leader in brain technology and precision neurotherapeutics, today announced that Baader Bank has initiated equity research coverage on the Company's shares.
Baader Bank has initiated coverage with a Buy recommendation and a target price of CHF 1.80 per share. This new coverage complements the existing research coverage provided by Edison Group, which currently values the Company at CHF 3.56 per share.
About MindMaze Therapeutics
MindMaze Therapeutics (SIX:MMTX) is a global leader in brain technology, dedicated to redefining the recovery trajectory for patients with neurological platform-based digital treatments. By integrating advanced software, proprietary sensors, and AI-driven data analytics, MindMaze Therapeutics provides a seamless continuum of care from the acute hospital phase to outpatient treatment to the home-based therapy. The Company's FDA-cleared and CE-marked neurotherapeutics are designed to address the systemic shortage of specialized clinicians, offering scalable, reimbursable solutions for stroke, Parkinson's disease, and other brain disorders. With a commitment to rigorous clinical validation and a robust R&D pipeline, MindMaze Therapeutics is operationalizing the future of neurorestorative medicine.
For more information, visit www.mindmazetherapeutics.com.
Media & Investor Contacts
Investor Relations:
Jeremy Meinen, Chief Financial Officer
[email protected]
Media Inquiries:
VSC for MindMaze Therapeutics
[email protected]
DISCLAIMER
This press release contains forward-looking statements, which may be identified by words such as "believe," "assume," "expect," "intend," "may," "could," "will," or similar expressions. These statements are based on current plans and assumptions and are subject to risks and uncertainties that could cause actual results, financial condition, performance, or achievements to differ materially from those expressed or implied. Such factors include, among others, business, economic, financial, regulatory, and competitive factors, as well as the Company's ability to execute its strategy. This communication is provided as of the date hereof, and MindMaze Therapeutics undertakes no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
SOURCE: MindMaze Therapeutics Holding SA
View the original press release on ACCESS Newswire
P.M.Smith--AMWN